Tiziana Life Sciences PLC logo
Tiziana Life Sciences PLC TLSA
€ 0.57 -7.35%
report update icon

Quartalsbericht 2024-Q4
hinzugefügt 21.11.2026

Tiziana Life Sciences PLC Betriebsaufwand | TLSA

Betriebsaufwand Jährlich Tiziana Life Sciences PLC

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
15.8 M 18 M 14.6 M 27.4 M - - - - - - - 289 K 263 K -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
27.4 M 263 K 12.7 M

Betriebsaufwand Vierteljährlich Tiziana Life Sciences PLC

2024-Q4 2023-Q4 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
15.8 M 18 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
18 M 15.8 M 16.9 M

Betriebsaufwand anderer Aktien in der Pharmaeinzelhändler

Name Betriebsaufwand Preis % 24h Marktkapitalisierung Land
Infinity Pharmaceuticals Infinity Pharmaceuticals
INFI
47.4 M - -46.98 % $ 3.57 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
29.8 M - - $ 7.46 M israelIsrael
Evelo Biosciences Evelo Biosciences
EVLO
108 M - -14.46 % $ 27.9 M usaUSA
Morphic Holding Morphic Holding
MORF
64 M - - $ 2.42 B usaUSA
Genocea Biosciences Genocea Biosciences
GNCA
53.7 M - -15.0 % $ 3.04 M usaUSA
Biogen Biogen
BIIB
7.49 B $ 249.55 0.98 % $ 36.6 B usaUSA
Bristol-Myers Squibb Company Bristol-Myers Squibb Company
BMY
34.3 B $ 58.74 0.69 % $ 119 B usaUSA
Eiger BioPharmaceuticals Eiger BioPharmaceuticals
EIGR
62.1 M - -9.21 % $ 2.55 M usaUSA
IGM Biosciences IGM Biosciences
IGMS
211 M - - $ 76.9 M usaUSA
Merrimack Pharmaceuticals Merrimack Pharmaceuticals
MACK
2.04 M - - $ 216 M usaUSA
Rubius Therapeutics Rubius Therapeutics
RUBY
178 M - -33.55 % $ 7.81 M usaUSA
Mirati Therapeutics Mirati Therapeutics
MRTX
772 M - - $ 3.3 B usaUSA
InVivo Therapeutics Holdings Corp. InVivo Therapeutics Holdings Corp.
NVIV
10.6 M - -37.48 % $ 476 K usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
28.5 M - -9.72 % $ 5.89 M usaUSA
Orchard Therapeutics plc Orchard Therapeutics plc
ORTX
159 M - 1.02 % $ 90.8 M britainBritain
La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company
LJPC
61.4 M - - $ 154 M usaUSA
Oyster Point Pharma Oyster Point Pharma
OYST
120 M - - $ 300 M usaUSA
Intercept Pharmaceuticals Intercept Pharmaceuticals
ICPT
95.1 M - - $ 643 M usaUSA
Chinook Therapeutics Chinook Therapeutics
KDNY
185 M - - $ 2.6 B usaUSA
Syros Pharmaceuticals Syros Pharmaceuticals
SYRS
139 M - -8.44 % $ 3.4 M usaUSA
NanoViricides NanoViricides
NNVC
8.31 M $ 1.15 -2.54 % $ 23.2 M usaUSA
GT Biopharma GT Biopharma
GTBP
13.6 M $ 2.93 -7.86 % $ 16.2 M usaUSA
Zymeworks Zymeworks
ZYME
53.2 M $ 26.41 -1.68 % $ 1.36 B canadaCanada
Aldeyra Therapeutics Aldeyra Therapeutics
ALDX
60.1 M $ 0.84 16.41 % $ 50.4 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
38.5 M $ 0.51 1.61 % $ 5.64 M usaUSA
Cytokinetics, Incorporated Cytokinetics, Incorporated
CYTK
700 M $ 50.7 -1.48 % $ 6.09 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
153 M $ 9.03 -4.14 % $ 1.26 B franceFrance
Precision BioSciences Precision BioSciences
DTIL
86.4 M $ 7.37 6.66 % $ 94.5 M usaUSA
Exelixis Exelixis
EXEL
1.36 B $ 64.59 -1.88 % $ 17.5 B usaUSA
Fennec Pharmaceuticals Fennec Pharmaceuticals
FENC
50.9 M $ 13.09 -2.68 % $ 374 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
49.6 M $ 0.85 -4.67 % $ 56.8 M usaUSA
BioNTech SE BioNTech SE
BNTX
512 M $ 80.87 -0.63 % $ 19.5 B germanyGermany
Alkermes plc Alkermes plc
ALKS
1.03 B $ 44.89 -2.79 % $ 7.39 B irlandaIrlanda
ANI Pharmaceuticals ANI Pharmaceuticals
ANIP
431 M $ 68.6 -0.77 % $ 1.38 B usaUSA
AIM ImmunoTech AIM ImmunoTech
AIM
11.7 M $ 0.11 -7.75 % $ 178 K usaUSA
AC Immune SA AC Immune SA
ACIU
72.9 M $ 1.98 -7.28 % $ 199 M schweizSchweiz
Atara Biotherapeutics Atara Biotherapeutics
ATRA
-35.9 M $ 6.51 2.6 % $ 81.7 M usaUSA
Allogene Therapeutics Allogene Therapeutics
ALLO
209 M $ 0.63 -5.62 % $ 139 M usaUSA
Altimmune Altimmune
ALT
94.5 M $ 1.33 -6.03 % $ 117 M usaUSA
AnaptysBio AnaptysBio
ANAB
20.7 M $ 46.65 -1.58 % $ 1.35 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
8.22 M - -1.52 % $ 24.7 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
761 M $ 252.39 -1.39 % $ 15.3 B danmarkDanmark
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
158 M $ 7.42 -2.37 % $ 203 M israelIsrael
Aurinia Pharmaceuticals Aurinia Pharmaceuticals
AUPH
43.9 M $ 14.7 -1.28 % $ 1.98 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
250 M $ 0.91 -6.96 % $ 242 M britainBritain
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
181 M $ 3.97 0.89 % $ 324 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
758 M $ 129.32 -4.69 % $ 6.43 B usaUSA
BridgeBio Pharma BridgeBio Pharma
BBIO
1 B $ 75.96 -2.84 % $ 14.5 B usaUSA
BioCryst Pharmaceuticals BioCryst Pharmaceuticals
BCRX
515 M $ 7.23 -1.3 % $ 1.52 B usaUSA
Bicycle Therapeutics plc Bicycle Therapeutics plc
BCYC
320 M $ 2.89 -5.25 % $ 200 M britainBritain